Biopharma’s drug quality efforts are hindered by a lack of data uniformity in the supply chain according to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), which has teamed up with Open Applications Group (OAGi) to encourage the adoption of common standards.
The partnership—announced in June —will focus on a...